Literature DB >> 26460876

Re: Clinical Efficacy of Collagenase Clostridium histolyticum in the Treatment of Peyronie's Disease by Subgroups: Results from Two Large, Double-blind, Randomized, Placebo-controlled, Phase III Studies.

Ates Kadioglu1, Abubekir Boyuk2, Emre Salabas2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26460876     DOI： 10.1016/j.eururo.2015.07.067

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  1 in total

1.  Results of SMSNA survey regarding complications following intralesional injection therapy with collagenase clostridium histolyticum for Peyronie's disease.

Authors:  Ates Kadioglu; Emre Salabas
Journal:  Transl Androl Urol       Date:  2017-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.